Literature DB >> 15652775

Mast cells and autoimmunity.

Menachem Rottem1, Yoseph A Mekori.   

Abstract

Mast cells (MCs) are major effector cells in allergic diseases. Recently, it has become evident that the contribution of MCs extends far beyond their accepted role in allergic disease, and that they play a more extensive role in a variety of non-allergic immune processes such as the innate immunity response. These cells have a key role in both the induction and elicitation of several autoimmune conditions. Targeting MC development, maturation or activation may be of value in future prevention and treatment of autoimmune conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652775     DOI: 10.1016/j.autrev.2004.05.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  17 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Notch2 paves the way to mast cells by Hes1 and Gata3.

Authors:  Priya Dedhia; Taku Kambayashi; Warren S Pear
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-30       Impact factor: 11.205

Review 3.  Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.

Authors:  Anastasia I Petra; Smaro Panagiotidou; Erifili Hatziagelaki; Julia M Stewart; Pio Conti; Theoharis C Theoharides
Journal:  Clin Ther       Date:  2015-05-01       Impact factor: 3.393

4.  Distinct roles of Ca2+ mobilization and G protein usage on regulation of Toll-like receptor function in human and murine mast cells.

Authors:  Asifa K Zaidi; Elden Retna Raj B Thangam; Hydar Ali
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

5.  JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis.

Authors:  Monica Guma; Jun-ichi Kashiwakura; Brian Crain; Yuko Kawakami; Bruce Beutler; Gary S Firestein; Toshiaki Kawakami; Michael Karin; Maripat Corr
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

6.  SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.

Authors:  Alexandra Taracanova; Mihail Alevizos; Anna Karagkouni; Zuiy Weng; Errol Norwitz; Pio Conti; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

Review 7.  Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactions.

Authors:  T C Theoharides; D Kempuraj; M Tagen; M Vasiadi; C L Cetrulo
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 8.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

9.  CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

Authors:  Ayumi Yoshizaki; Yohei Iwata; Kazuhiro Komura; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

10.  CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells.

Authors:  Yongfeng Jiang; Laura A Borrelli; Yoshihide Kanaoka; Brian J Bacskai; Joshua A Boyce
Journal:  Blood       Date:  2007-08-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.